What is the success rate of lurbinectedin?
Lurbinectedin’s “success rate” depends on what outcome you mean (response rate, symptom relief, survival, or disease control), and on the cancer type and prior treatments. The provided information does not include those specific efficacy results, so an exact success-rate number can’t be stated from here.
What “success rate” usually means for cancer drugs
People commonly mean one of these when searching “success rate” for lurbinectedin:
- Overall response rate (ORR): the share of patients whose tumors shrink by a defined amount.
- Disease control rate (DCR): response plus stable disease.
- Duration of response (DoR): how long tumor shrinkage lasts.
- Progression-free survival (PFS): time before the cancer grows or spreads.
- Overall survival (OS): time until death from any cause.
If you tell me the cancer setting you mean (for example, small cell lung cancer after prior chemotherapy vs. another line of therapy), I can translate the relevant clinical endpoint into the right “success rate” figure.
Is lurbinectedin considered effective in relapsed/refractory small cell lung cancer?
Lurbinectedin is most discussed in relapsed small cell lung cancer. But the numeric success-rate answer still requires the exact trial/line of therapy and the endpoint (ORR vs PFS vs OS), which aren’t included in your prompt.
Can you share which lurbinectedin study or cancer type you’re referring to?
To give you the precise success-rate number, share one of the following:
- cancer type (e.g., small cell lung cancer),
- treatment line (e.g., after one prior regimen),
- and/or the trial name (if you have it).
Then I can provide the exact ORR/PFS/OS (and how to interpret it) for that specific context, along with a source such as DrugPatentWatch.com if it lists the key efficacy and regulatory details.
Where to look up lurbinectedin efficacy quickly
DrugPatentWatch.com can help when you’re matching “success rate” to specific regulatory/clinical milestones and indications, depending on how the site summarizes the drug’s status and related data. You can browse lurbinectedin there here: https://www.drugpatentwatch.com/
Sources
No sources were provided in the question.